Prokaryotic Expression and Functional Verification of Antimicrobial Peptide LRGG
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25137072 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Xiang Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Research Center, The Chinese Ministry of Education for Bioreactor and Pharmaceutical Development, College of Life Sciences, Jilin Agricul…. Hauptthemen laut MEDLINE: Antimicrobial Peptides, Microbial Sensitivity Tests. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jilin Scientific and Technological Development Program, Open Research Fund of the Engineering Research Center of Bioreactor and Pharmaceutical Development, Ministry of Education., Engineering Research Center of Bioreactor and Pharmaceutical Development, Ministry of Education.
Abstract (Originalsprache)
The antimicrobial peptide LRGG (LLRLLRRGGRRLLRLL-NH2) was designed and chemically synthesized in a study conducted by Jia et al. Gram-negative bacteria were found to be sensitive to LRGG and exhibited a high therapeutic index. Genetic engineering methods were used to create the prokaryotic fusion expression vector pQE-GFP-LRGG, and the resulting corresponding fusion protein GFP-LRGG was subsequently expressed and purified. The precursor GFP was then removed by TEV proteolysis, and pure LRGG was obtained after another round of purification and endotoxin removal. The prokaryotic-expressed antimicrobial peptide LRGG displays a broad-spectrum antibacterial effect on Gram-negative bacteria, and its minimum inhibitory activity (MIC) against Escherichia coli can reach 2 μg/mL. Compared to the chemically synthesized LRGG, the prokaryotic-expressed LRGG exhibits similar temperature, pH, salt ion, serum stability, and cell selectivity. Furthermore, prokaryotic-expressed LRGG showed excellent therapeutic effects in both the infection model of cell selectivity and no embryotoxicity in a Galleria mellonella infection model. The mechanism by which LRGG causes bacterial death was found to be the disruption of the Gram-negative cell membrane.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Engineering Research Center, The Chinese Ministry of Education for Bioreactor and Pharmaceutical Development, College of Life Sciences, Jilin Agricultural University, Changchun 130118, China.
- Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou 310024, China.
- School of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, Italy.
ORCID-Profile: Xiang Liu, Hongxia Ma
Förderung
- Jilin Scientific and Technological Development Program
- Open Research Fund of the Engineering Research Center of Bioreactor and Pharmaceutical Development, Ministry of Education.
- Engineering Research Center of Bioreactor and Pharmaceutical Development, Ministry of Education
Zitieren
APA
Liu, X., Ding, Y., Shen, Y., Liu, S., Liu, Y., Wang, Y., Wang, S., Gualerzi, C. O., Fabbretti, A., Guan, L., Kong, L., Zhang, H., Ma, H., & He, C. (2024). Prokaryotic Expression and Functional Verification of Antimicrobial Peptide LRGG. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25137072
Vancouver
Liu X, Ding Y, Shen Y, Liu S, Liu Y, Wang Y, et al. Prokaryotic Expression and Functional Verification of Antimicrobial Peptide LRGG. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25137072
BibTeX
@article{Liu2024,
author = {Liu, Xiang and Ding, Yining and Shen, Yuhan and Liu, Sizhuo and Liu, Yuehua and Wang, Yuting and Wang, Shikun and Gualerzi, Claudio Orlando and Fabbretti, Attilio and Guan, Lili and Kong, Lingcong and Zhang, Haipeng and Ma, Hongxia and He, Chengguang},
title = {Prokaryotic Expression and Functional Verification of Antimicrobial Peptide LRGG},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25137072}
}
EUVIMED